Increased serum neutral endopeptidase activity in acute renal allograft rejection

American Journal of Nephrology

Volumn 16, Issue 4, 1996, Pages 273-279

  Tikkanen, Ilkka ^a   Salmela, Kaija ^a   Hohenthal, Ulla ^a   Teppo, Anna Maija ^a   Pakkala, Seppo ^b   Ahonen, Juhani ^a   Fyhrquist, Frej ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Acute allograft rejection; CD 10 antigen; Neutral endopeptidase; Renal transplantation

Indexed keywords

C REACTIVE PROTEIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MEMBRANE METALLOENDOPEPTIDASE;

ADULT; ARTICLE; ASPIRATION BIOPSY; BLOOD LEVEL; CLINICAL ARTICLE; ENZYMATIC ASSAY; ENZYME ACTIVITY; FEMALE; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE EPITHELIUM; MALE; PRIORITY JOURNAL;

EID: 0029928978     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000169009     Document Type: Article

References (27)

1. Kenny AJ, O’Harc MJ, Gusterson BA: Cell surface peptidases as modulators of growth and differentiation. Lancet 1987;ii:785-787.
2. Clark EA, Ledbetter J A: Leukocyte cell surface enzymology: CD45 (LCA, T200) is a protein tyrosine phosphatase. Immunol Today 1989; 10:225-228.
3. Shipp MA, Vijayaraghavan J, Schmidt EV, Masteller EL, D’Adamio L, Hersh LB, Rein-herz EL: Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endo-pcptidase 24.11 (‘enkephalinase’): Direct evidence by cDNA transfection analysis. Proc Natl Acad Sci USA 1989;86:297-301.
4. Kenny AJ, Stephenson SL, Turner AJ: Cell surface peptidases; in Kenny AJ. Turner AJ (eds): Mammalian Ectoenzymcs. Amsterdam, Elsevier, 1987, pp 169-210.
5. Kenny AJ, Bowes MA, Gee NS, Matsas R: Endopeptidase 24.11: A cell surface enzyme for metabolizing regulatory peptides. Biochem Soc Trans 1985;13:293-295.
6. Erdos EG, Skidgel RA: Neutral endopeptidase 24.11 (enkephalinase) and related regulators of pept ide hormones. FASEB J 1989:3:145-151.
7. Howell S, Murray H, Scott CS, Turner AJ, Kenny AJ: A highly sensitive ELISA for endopeptidase 24.11, the common acutc-lympho-blastic-leukaemia antigen (CALLA, CD-10), applicable to material of porcine and human origin. Biochem J 1991;278:417-421.
8. LeBien TW, McCormack RT: The common acute lymphoblastic leukemia antigen (CD 10): Emancipation from a functional enigma. Blood 1989:73:625-635.
9. Erdos EG, Wagner B, Harbury CB, Painter RG, Skidgel RA, Fa X-G: Down-regulation and inactivation of neutral endopeptidase 24.11 (enkephalinase) in human neutrophils. J Biol Chem 1989;264:14519-14523.
10. Shipp MA, Stefano GB, Switzer SN, Griffin JD, Reinherz EL: CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology. migration, and adhesion proteins and is itself regulated by neutrophil activation. Blood 1991;78:1834-1841.
11. Shipp MA, Tarr GE, Chen C-Y, Switzer SN, Hersh LB, Stein H, Sunday ME, Reinhcrz EL: CDIO/ncutral endopeptidase 24.11 hydrolyzes bombcsin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc Natl Acad Sci USA 1991:88:10662-10666.
12. Hayry P, von Willebrand E, Parthcnais E, Nemlander A, Soots A, Lautenschlager I, Alfol-dy P. Rcnkonen R: The inflammatory mechanisms of allograft rejection. Immunol Rev 1984;77:85-142.
13. Horejsi V: Surface antigens of human leukocytes. Adv Immunol 1991:49:75-147.
14. Hall BM: Cells mediating allograft rejection. Transplantation 1991;51:1141 -1151.
15. Isoniemi H, Ahonen J, Eklund B, Hockerstedt K, Salmela K, von Willebrand E, Havry P: Renal allograft immunosuppression. L Early inflammatory and rejection episodes in triple drug treatment compared to double drug combinations or cyclosporin monotherapy. Transplant Int 1990;3:92-97.
16. Isoniemi HM, Krogerus L, von Willebrand E, Taskinen E, Ahonen J, Hayry P: Histopatho-logical findings in well-functioning, long-term renal allografts. Kidney Int 1992;41:155-160.
17. Spillantini MG, Geppetti P, Fanciullacci M, Michclacci S, Lecomte JM, Sicuteri F: In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF. Eur J Pharmacol 1986; 125:147-150.
18. Spillantini MG, Panconesi A, Del Bianco PL, Sicuteri F: Enkephalinase and angiotensin converting enzyme activities in human venous and arterial plasma. Neuropeptides 1986:8:111-117.
19. Deschodt-Lanckman M, Michaux F, De Prez E, Abramowicz D, Vanherweghem J-L, Goldman M: Increased serum levels of endopeptidase 24.11 (‘enkephalinase’) in patients with end-stage renal failure. Life Sci 1989:45:133-141.
20. Roques BP, Beaumont A: Neutral endopepti-dase 24.11 inhibitors: From analgesics to antihypertensives. Trends Pharmacol Sci 1990,11: 245-249.
21. Hâyry P, von Willebrand E: Practical guidelines for fine needle aspiration biopsy of human renal allografts. Ann Clin Res 1981:13: 288-306.
22. Maury CPJ, Teppo A-M: Comparative study of serum amyloid-related protein SAA, C-reactivc protein, and pi-microglobulin as markers of renal allograft rejection. Clin Nephrol 1984:22: 284-292.
23. von Willebrand E, Zola H, Hâyry P: Thrombocyte aggregates in renal allografts: Analysis by the fine needle aspiration biopsy and monoclonal anti-thrombocyte antibodies. Transplantation 1985;39:259-262.
24. Johnson AR, Coalson JJ, Ashton J, Larumbide M, Erdos EG: Neutral endopeptidase in serum samples from patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985: 132:1262-1267.
25. Almcnoff J, Teirslein AS: Clinical significance of scrum thermolysin-likc metalloendopepti-dase and its relationship to serum angiotensin converting enzyme in sarcoidosis. Am J Med 1987;82:33-38.
26. Yandle T, Richards M, Smith M, Charles C, Livesey J, Espiner E: Assay of endopeptidase 24.11 activity in plasma applied to in vivo studies of endopeptidase inhibitors. Clin Chem 1992;38:1785-1791.
27. Nortier J, Abramowicz D, Najdowski T, Kin-naert P, Vanherweghem J-L, Goldman M, De-schodt-Lanckman M: Urinary endopeptidase 24.11 as a new marker of proximal tubular injury: Preliminary study in kidney transplant recipients; in Bianchi C. Bocci V. Carone FA. Rabkin R (eds): Kidney, Proteins and Drugs: An Update. Contrib Nephrol. Basel, Karger. 1993. vol 101. pp 169-176.